Abbott Point of Care, Inc.

Abbott Point of Care, Inc. — FDA 510(k) Submissions

Abbott Point of Care, Inc. has submitted 19 FDA 510(k) premarket notifications since 2011, of which 19 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Glucose Oxidase, Glucose, Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph, Electrode, Ion Specific, Sodium, Electrode, Ion Specific, Calcium, System, Test, Human Chorionic Gonadotropin . Use the specialty filter in the sidebar to narrow results.